Compare Johnson & Johnson (JNJ) vs Zillow Group Inc Class C (Z) Price & Performance

Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.

JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.

Zillow Group (Z) trades at $29.17, up 6.93% in the past 24 hours, showing strong momentum despite mixed technical signals. The company has demonstrated improving fundamentals with revenue growing from $2.2B in 2024 to $2.6B in 2025, and net income turning positive at $23M after a $112M loss the prior year. Recent earnings show two consecutive beats, with Q2 2026 EPS of $0.52 exceeding expectations of $0.4459. Analyst consensus remains divided with a $60.33 price target representing significant upside potential from current levels.

The outlook for Zillow appears cautiously optimistic with improving profitability and strategic AI integration, though the stock faces headwinds from high mortgage rates and housing market volatility. The company's transition to an integrated transaction platform shows promise, but execution risks remain amid competitive pressures and regulatory scrutiny. With a P/E ratio of 126.83 indicating premium valuation, investors should monitor housing market trends and the company's ability to sustain recent earnings momentum.